Everolimus
(asked on 14th December 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions Solutions for Public Health has had with the European Medicines Agency and US Food and Drug Administration on developing a draft commissioning policy for everolimus.
This question was answered on 17th December 2015
Solutions for Public Health has confirmed that they have not had any discussions with either the European Medicines Agency or US Food and Drug Administration in relation to Everolimus.
This is outside of the scope of the evidence review methodology commissioned by NHS England and would not be relevant to their role as a provider of stand-alone clinical evidence reviews.